Group One Trading’s Bicycle Therapeutics BCYC Stock Holding History

Group One Trading’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.22K	Buy	+1,938	New	+$8.88K	﹤0.01%	6518
2025 Q3	–	Sell	-1,294	Closed	-$9.77K	–	8403
2025 Q2	$8.99K	Buy	1,294 +1,128	+680%	+$8.98K	﹤0.01%	6786
2025 Q1	$1.41K	Sell	166 -300	-64%	-$3.54K	﹤0.01%	7100
2024 Q4	$6.52K	Buy	+466	New	+$9.99K	﹤0.01%	6306
2024 Q2	–	Sell	-91	Closed	-$2.06K	–	6718
2024 Q1	$2.27K	Sell	91 -26,173	-100%	-$556K	﹤0.01%	6457
2023 Q4	$475K	Sell	26,264 -54,962	-68%	-$909K	﹤0.01%	3121
2023 Q3	$1.63M	Sell	81,226 -2,741	-3%	-$62.7K	0.01%	1820
2023 Q2	$2.14M	Buy	83,967 +35,528	+73%	+$825K	0.01%	1657
2023 Q1	$1.03M	Buy	48,439 +9,655	+25%	+$242K	﹤0.01%	2118
2022 Q4	$1.15M	Buy	+38,784	New	+$1.04M	﹤0.01%	2293

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Group One Trading's BCYC Position: Q2 2026 in Review

Group One Trading opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 1,938 shares worth $8.22K. The stake represents ﹤0.01% of the portfolio and ranks #6518 among its holdings. This is a return to the name: Group One Trading previously reported a position in BCYC as recently as Q2 2025.

Group One Trading first reported a position in BCYC in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.14M in Q2 2023. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Group One Trading held 1,938 shares of Bicycle Therapeutics worth $8.22K as of Q2 2026.
Bicycle Therapeutics was a new Group One Trading position in Q2 2026.
Bicycle Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6518 holding.
Group One Trading first reported a position in Bicycle Therapeutics in Q4 2022 and has held it in 10 quarters since.
Group One Trading's Bicycle Therapeutics position peaked at $2.14M in Q2 2023.
103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.